Artemisinin

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51101900
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51101920

This classification denotes an antiprotozoal agent with the molecular formula C15H22O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9RMU91N5K2, chemically known as 3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one, octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)- but generally known as artemisinin, which bears US NIH Compound Identifier 68827. artemisinin most often comes in base, type a, and type b forms. European Medicines Agency schedules Artemisinin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05575MIG. The term ARTEMISININ is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules artemisinin in its Anatomical Therapeutic Chemical (ATC) Classification. ARTEMISININ is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule artemisinin under HS 29329985 and SITC 51569. As of Q4 2014, ARTEMISININ remains the US FDA Preferred Term for this commodity. Artemisinin bears US NLM identifiers UMLS ID C0052430 and NCI Concept Code C78093. SMILES: O1OC2(OC3OC(=O)C(C4C13C(C(CC4)C)CC2)C)C.

Same parent

Under 51101900 · 37

51101902 Mefloquine Commodity 51101903 Primaquine Commodity 51101904 Quinine Commodity 51101905 Chloroquine Commodity 51101906 Proguanil Commodity 51101907 Pyrimethamine Commodity 51101908 Artemether Commodity 51101911 Halofantrine Commodity 51101912 Hydroxychloroquine Commodity 51101913 Amodiaquine Commodity 51101914 Artesunate Commodity 51101915 Benflumetol or lumefantrine Commodity 51101916 Amopyroquine Commodity 51101917 Amquinate Commodity 51101918 Artemotil or beta-arteether Commodity 51101919 Arteflene Commodity 51101920 Artemisinin You are here 51101921 Chlorproguanil Commodity 51101922 Artenimol Commodity 51101923 Atovaquone Commodity 51101924 Bulaquine Commodity 51101925 Chininum muriaticum Commodity 51101926 Chloroguanide Commodity 51101927 Cloquinate Commodity 51101928 Cycloguanil Commodity 51101929 Docetaxel Commodity 51101930 Enpiroline Commodity 51101931 Quinocide Commodity 51101932 Menoctone Commodity 51101933 Mepacrine Commodity 51101934 Moxipraquine Commodity 51101935 Pamaquine Commodity 51101936 Sitamaquine Commodity 51101937 Tafenoquine Commodity 51101938 Tebuquine Commodity 51101939 Acediasulfone Commodity 51101940 Cycloguanil embonate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51100000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.